No takes yet. Share an insight, caveat, or question.
Randomized trial investigates PMP22 protein effects on myelin in Schwann cells, suggesting mechanisms for CMT diseases.
Wilkinson et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: